Gene description for SERINC3
Gene name serine incorporator 3
Gene symbol SERINC3
Other names/aliases AIGP1
DIFF33
SBBI99
TDE
TDE1
TMS-1
Species Homo sapiens
 Database cross references - SERINC3
ExoCarta ExoCarta_10955
Entrez Gene 10955
HGNC 11699
MIM 607165
UniProt Q13530  
 SERINC3 identified in exosomes derived from the following tissue/cell type
Prostate cancer cells 25844599    
Prostate cancer cells 25844599    
 Gene ontology annotations for SERINC3
Molecular Function
    L-serine transmembrane transporter activity GO:0015194 IBA
Biological Process
    phosphatidylserine metabolic process GO:0006658 IEA
    L-serine transport GO:0015825 IBA
    positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902237 IEA
    sphingolipid metabolic process GO:0006665 IEA
Subcellular Localization
    integral component of membrane GO:0016021 IEA
    Golgi apparatus GO:0005794 IEA
    plasma membrane GO:0005886 IEA
 Experiment description of studies that identified SERINC3 in exosomes
1
Experiment ID 275
ISEV standards
EM
EV Biophysical techniques
TSG101|Alix|RAB5A
EV Cytosolic markers
CD9|CD82|CD63|CD81
EV Membrane markers
AIF
EV Negative markers
NTA
EV Particle analysis
Identified molecule protein
Identification method Mass spectrometry
PubMed ID 25844599    
Organism Homo sapiens
Experiment description Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Authors Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year 2015
Sample Prostate cancer cells
Sample name DU145 - Docetaxel sensitive
Isolation/purification methods Filtration
Ultracentrifugation
Sucrose density gradient
Flotation density 1.12-1.19 g/mL
Molecules identified in the study Protein
Methods used in the study Mass spectrometry/Flow cytometry/Western blotting
2
Experiment ID 274
ISEV standards
EM
EV Biophysical techniques
TSG101|Alix|RAB5A
EV Cytosolic markers
CD9|CD82|CD63|CD81
EV Membrane markers
AIF
EV Negative markers
NTA
EV Particle analysis
Identified molecule protein
Identification method Mass spectrometry
PubMed ID 25844599    
Organism Homo sapiens
Experiment description Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Authors Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year 2015
Sample Prostate cancer cells
Sample name DU145 - Docetaxel resistant
Isolation/purification methods Filtration
Ultracentrifugation
Sucrose density gradient
Flotation density 1.13-1.18 g/mL
Molecules identified in the study Protein
Methods used in the study Mass spectrometry
Flow cytometry
Western blotting
 Protein-protein interactions for SERINC3
  Protein Interactor ExoCarta ID Identification method PubMed Species
1 SLC16A1 6566
Affinity Capture-MS Homo sapiens
2 KDELR1 10945
Affinity Capture-MS Homo sapiens
3 HACD3 51495
Affinity Capture-MS Homo sapiens
4 XPO5 57510
Affinity Capture-MS Homo sapiens
5 PHB2 11331
Affinity Capture-MS Homo sapiens
6 SURF4 6836
Affinity Capture-MS Homo sapiens
7 KDELR2 11014
Affinity Capture-MS Homo sapiens
8 VDAC2 7417
Affinity Capture-MS Homo sapiens
View the network image/svg+xml
 Pathways in which SERINC3 is involved
No pathways found





Perform bioinformatics analysis of your extracellular vesicle data set using FunRich, a open access standalone tool. NEW UPDATED VERSION OF FunRich available for download (12/09/2016) from here